(Q72246149)
Statements
Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging (English)
Hamm B
Staks T
Mühler A
Bollow M
Taupitz M
Frenzel T
Wolf KJ
Weinmann HJ